These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2554709)

  • 1. Vascular effects of calcium antagonists: implications for hypertension and other risk factors for coronary heart disease.
    van Zwieten PA
    Am J Cardiol; 1989 Nov; 64(17):117I-121I. PubMed ID: 2554709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor subtypes involved in the action of calcium antagonists.
    van Zwieten PA; Timmermans PB; van Heiningen PN
    J Hypertens Suppl; 1987 Dec; 5(4):S21-8. PubMed ID: 2450185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interaction between calcium antagonists and vascular postsynaptic alpha-receptors].
    van Meel JC; Timmermans PB; van Zwieten PA
    J Pharmacol; 1982; 13(3):367-79. PubMed ID: 6290792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical benefits of structural and functional changes with calcium antagonists.
    O'Malley K; Kelly J; O'Brien E
    Am Heart J; 1991 Jul; 122(1 Pt 2):370-4. PubMed ID: 1828936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and counterregulatory effects of calcium antagonists in hypertension.
    Kiowski W; Bolli P; Erne P; Hulthén UL; Müller FB; Bühler FR
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S39-43. PubMed ID: 2468904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
    Frohlich ED
    Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of action and clinical use of calcium antagonists in hypertension.
    Kiowski W; Bolli P; Erne P; Müller FB; Hulthén UL; Bühler FR
    Circulation; 1989 Dec; 80(6 Suppl):IV136-44. PubMed ID: 2557176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological aspects of calcium antagonism. Short term and long term benefits.
    Nayler WG
    Drugs; 1993; 46 Suppl 2():40-7. PubMed ID: 7512481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tissue selectivity of calcium channel blockers].
    Godfraind T
    C R Seances Soc Biol Fil; 1998; 192(1):121-35. PubMed ID: 9759358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonist drugs in hypertensive patients with angina pectoris.
    Just H; Frey M; Zehender M
    Eur Heart J; 1996 Dec; 17 Suppl G():20-4. PubMed ID: 8960451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-channel blockers for combined angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Kimmel B; Goldberger J; Phillippides G; Klein N
    Am J Cardiol; 1986 Feb; 57(7):22D-29D. PubMed ID: 3513513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological basis for use of calcium channel antagonists in hypertension.
    Scriabine A; Kazda S; Garthoff B; Nickerson PA
    Angiology; 1988 Jan; 39(1 Pt 2):94-9. PubMed ID: 2449099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The actions and role of calcium entry blockers in hypertension: cardiac considerations.
    Sole MJ
    Clin Invest Med; 1989 Oct; 12(5):294-9. PubMed ID: 2689025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of calcium antagonists in hypertension.
    Kiowski W; Bolli P; Erne P; Hulthén UL; Bühler FR
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S23-8. PubMed ID: 2455134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay of ischemic and hypertensive pathophysiology on cardiac function.
    Frishman WH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S17-21. PubMed ID: 1721974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological basis for use of calcium antagonists in hypertension.
    Scriabine A; Kazda S
    Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of calcium antagonists in cardiovascular therapy.
    Dargie H; Rowland E; Krikler D
    Br Heart J; 1981 Jul; 46(1):8-16. PubMed ID: 7023517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular versus myocardial selectivity of calcium antagonists.
    Sheridan DJ; Thomas P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S165-8. PubMed ID: 2442511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.